Monday, September 30, 2024
HomeNews

News

Novavax COVID-19 Vaccine Nuvaxovid Recommended for Expanded Conditional Marketing Authorization

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that the Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine has...

RegeneRx Licensee to Expand Phase 3 Clinical Trial Program with RGN-259

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting that its U.S. joint venture (JV) partner...

Boehringer Ingelheim Canada Partners with Plug and Play Alberta to Advance Digital Health Innovation

Plug and Play Tech Center, a global innovation platform, announced a new partnership with Boehringer Ingelheim (Canada) Ltd., a leading research-driven biopharmaceutical company. Boehringer-Ingelheim...

Rockwell Medical Provides Corporate and Clinical Update

Rockwell Medical, Inc., a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients, provided an...

Mojia Biotech Completes Series B Financing to Advance Manufacturing of Bio-based Materials

Mojia Biotech, a Shanghai-based leading bio-manufacturing company dedicated to sustainable development and carbon neutrality, announced the completion of an $80 million Series B Financing....
0FansLike
0FollowersFollow
spot_img

Hot Topics